
Reena Pharma India Private Limited
Manufacturer of chemical elements, intermediates, and specialty chemicals for pharma and cosmetic industry.
Manufacturer of chemical elements, intermediates, and specialty chemicals for pharma and cosmetic industry.
Reena Pharma India Private Limited (RPIPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 July 2001 and has a history of 23 years and ten months. Its registered office is in Navi Mumbai, Maharashtra.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.95 M.
The company currently has active open charges totaling ₹8.80 M. The company has closed loans amounting to ₹6.91 Cr, as per Ministry of Corporate Affairs (MCA) records.
Shivagouda Patil, Savita Patil, Shashidhar Patil, and Two other members serve as directors at the Company.
+91-XXXXXXXXXX
U24231MH2001PTC132736
132736
Private Limited Indian Non-Government Company
16 Jul 2001
30 Sep 2023
31 Mar 2023
Unlisted
Roc Mumbai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Shivagouda Patil ![]() | Director | 16-Jul-2001 | Current |
Savita Patil ![]() | Director | 16-Jul-2001 | Current |
Shashidhar Patil ![]() | Director | 01-Jul-2013 | Current |
Haresh Mehta ![]() | Director | 01-Nov-2012 | Current |
Ila Mehta ![]() | Director | 01-Nov-2012 | Current |
Reena Pharma India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 78.73% increase. The company also saw a substantial improvement in profitability, with a 109.16% increase in profit. The company's net worth moved up by a moderate rise of 3.85%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Reena Pharma India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Haresh Mehta and Ila Mehta are mutual person
₹8.80 M
₹69.06 M
Date | Lender | Amount | Status |
---|---|---|---|
29 Mar 2024 | Others | ₹5.10 M | Open |
11 Aug 2021 | New India Co-Op Bank Limited | ₹1.70 M | Open |
27 Jun 2018 | New India Co-Op Bank Limited | ₹2.00 M | Open |
07 Apr 2014 | New India Co-Op Bank Limited | ₹1.50 Cr | Satisfied |
07 Apr 2014 | New India Co-Op Bank Limited | ₹1.50 Cr | Satisfied |
Reena Pharma India has a workforce of 7 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Reena Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Reena Pharma India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others amounted to Rs. 5.10 M with Charge ID 100900828 was registered on 29 Mar 2024.
Reena Pharma India Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Reena Pharma India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
A charge with New India Co-Op Bank Limited amounted to Rs. 1.70 M with Charge ID 100470762 was registered on 11 Aug 2021.
A charge registered on 07 Apr 2014 via Charge ID 10496928 with New India Co-Op Bank Limited was fully satisfied on 21 Aug 2019.
A charge registered on 07 Apr 2014 via Charge ID 10496931 with New India Co-Op Bank Limited was fully satisfied on 21 Aug 2019.
Reena Pharma India Private Limited was incorporated on 16 Jul 2001.
The authorized share capital of Reena Pharma India Private Limited is ₹ 2.00 M and paid-up capital is ₹ 1.95 M.
Currently 5 directors are associated with Reena Pharma India Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Reena Pharma India Private Limited is Plot No A-146/6 Ttc Indusrtial Area Midc Kherane, Thane Belapur Road India, Navi Mumbai, Maharashtra, 400705.
The corporate identification number (CIN) of Reena Pharma India Private Limited is U24231MH2001PTC132736 and the company number is 132736 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Reena Pharma India Private Limited has risen by 78.73%.
As Per 2023 financial reports, 7 employees are currently employed by Reena Pharma India Private Limited.
The financial reports for the fiscal year 2023 indicates that The net worth of Reena Pharma India Private Limited has experienced an upsurge of 3.85%.
As per the financial statements for fiscal Year 2023, The total open charges for Reena Pharma India Private Limited amount to ₹ 8.80 M.
The most recent Balance Sheet for Reena Pharma India Private Limited was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.